Benfotiamine

Benfotiamine

Benfotiamine

Min.Order / FOB Price:Get Latest Price

1 Kilogram

FOB Price: USD 100.0000

  • Min.Order :1 Kilogram
  • Purity: 98%
  • Payment Terms : L/C,D/P,T/T,

Keywords

Benfotiamine 13708-63-9 Benfotiamine Powder

Quick Details

  • Appearance:Raw Material Powder
  • Application:APIS
  • PackAge:1kg, 5kg, 10kg per bag, 25kg/drum or customized
  • ProductionCapacity:50|Metric Ton|Day
  • Storage:Sealed, Cool and Dry Place
  • Transportation:100kg below by express, 100-500kg by air or by sea or by train

Superiority:

1. Any inquiries will be replied within 12 hours.
2. Dedication to quality, supply & service.
3. Strictly on selecting raw materials.
4. OEM/ODM Available.
5. Reasonable & competitive price, fast lead time.
6. Sample is available for your evaluation & Formulation development.
7. Faster delivery:Sample order in stock and 3-7 days for bulk production.
8. We have strong cooperation with DHL, TNT, UPS, FEDEX, EMS. Or you also can choose your own shipping forwarder.
9. After-Sale Service:
(1) International Authorized Third-Party Test For The Products You Demand.
(2) 60 Days Warranty of quality of goods.

 

Details:

ertificate of Analysis

Test

Specifications

Result

Assay

≥98.0%

Complies

Appearance

A white to off-white crystalline powder

Complies

Identification

IR

Water

≤ 1.5%  

0.4%

Chloride

≤0.053%

0.031%

Sulphate

≤0.011%

0.005%

Thiamine

≤0.1%

0.06%

Benzoic acid

Negative

Complies

Melting point

≤ 200℃

Complies

Heavy metal

≤ 20ppm

<10ppm

Conclusion

Conform with In house Standard


Function&Application

Benfotiamine is useful for the treatment of diabetic retinopathy, neuropathy, and nephropathy however "Most of the effects attributed to benfotiamine are extrapolated from in vitro and animal studies. Unfortunately apparent evidences from human studies are scarce and especially endpoint studies are missing. Therefore additional clinical studies are mandatory to explore the therapeutic potential of benfotiamine in both diabetic and non-diabetic pathological conditions".

 

It is thought that treatment with benfotiamine leads to increased intracellularthiamine diphosphate levels, a cofactor of transketolase. This enzyme directs advanced glycation and lipoxidation end products (AGE's, ALE's) substrates to the pentose phosphate pathway, thus reducing tissue AGEs.

 

1. Benfotiamine is used for the prevention and treatment of vitamin B1 deficiency;

2. For vitamin B1 demand increase, with inadequate intake from foods supplies (fatigue, hyperthyroidism, pregnancy, lactation, during strenuous manual labor, etc.);

3. Benfotiamine is used in the treatment of non alcoholic wernicke encephalopathy;

4. To treat beriberi;

5. Used in the following diseases, speculation and vitamin B1 deficiency and metabolic disorders associated with treatment, such as: neuralgia; Muscle pain, joint pain; Peripheral neuritis, peripheral nerve palsy; Myocardial metabolic disorders; Constipation and other gastrointestinal motor function obstacle.

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View